Browse Related Topics For:

ANDA

118
Patents
97
Pharmaceutical
74
Patent Litigation
70
Pharmaceutical Patents
64
Generic Drugs
53
Patent Infringement
41
Prescription Drugs
40
FDA
38
Pharmaceutical Manufacturers
27
Hatch-Waxman
27
Reverse Payment Settlement Agreements
23
SCOTUS
22
FTC
21
FTC v Actavis
19
Biotechnology
16
Mylan Pharmaceuticals
14
Infringement
13
Actavis Inc.
11
Obviousness
11
Teva Pharmaceuticals
10
Patent-in-Suit
10
Watson Pharmaceuticals
9
Antitrust Litigation
9
Apotex
9
Pay-For-Delay
9
Pfizer
8
Claim Construction
8
Drug Manufacturers
8
Jurisdiction
6
AstraZeneca
6
Prior Art
5
Actavis
5
Appeals
5
FDCA
5
Merck
5
Popular
5
Sandoz
4
Cephalon
4
DaimlerAG
4
Generic
4
Labeling
4
Motion to Dismiss
4
Personal Jurisdiction
4
Sherman Act
3
Allergan Inc
3
Amgen
3
Anti-Competitive
3
Antitrust Provisions
3
BPCIA
3
DaimlerChrysler v Bauman
3
Eli Lilly
3
Induced Infringement
3
Intellectual Property Litigation
3
Life Sciences
3
Manufacturers
3
Medicare Modernization Act
3
Novartis
3
Par Pharmaceutical
3
Safe Harbors
3
Settlement
3
Written Descriptions
2
Antitrust Investigations
2
Biologics
2
Biosimilars
2
Bristol-Myers Squibb
2
Cadence Pharmaceuticals Inc.
2
Certiorari
2
Class Action
2
Declaratory Judgments
2
Enablement Inquiries
2
Failure To Warn
2
Forum
2
GlaxoSmithKline
2
Noninfringement
2
Orange Book
2
Patent Applications
2
Patent Trial and Appeal Board
2
Preliminary Injunctions
2
Prometheus
2
RanBaxy
2
Spectrum v Sandoz
2
Subject Matter Jurisdiction
2
Takeda Pharmaceuticals
2
Trademarks
2
USPTO
1
Administrative Procedure Act
1
Advertising
1
Allergan v. Barr Laboratories
1
Amazon
1
Ambiguous
1
Arbitration
1
Arbitration Agreements
1
Bausch & Lomb
1
Bayer
1
Biopharmaceutical
1
Brand
1
Burden of Proof
1
CA Supreme Court
1
Certifications
1
Chilcott v Teva
1
Cipro
1
Citizen Petitions
1
Claim Preclusion
1
Claims Limitations Period
1
Classen Immunotherapies
1
Clear and Convincing Evidence
1
Combination Products
1
Competition
1
Complex Litigation
1
Contract Drafting
1
Copaxone
1
Copyright
1
Corporate Counsel
1
Counterclaims
1
Crestor
1
Daiichi Sankyo
1
Duty to Deal
1
E-Filing
1
Elan Pharmaceuticals
1
Exclusivity
1
Exemptions
1
Expert Testimony
1
Expert Witness
1
FDASIA
1
Federal Jurisdiction
1
Federal Rule 12(b)(6)
1
FENTORA
1
First Amendment
1
Fresenius
1
Genzyme
1
Good Faith
1
Government Investigations
1
Healthcare
1
HHS
1
Hoffman LaRoche
1
Indefiniteness
1
Information Reports
1
Integra
1
Inter Partes Reexamination
1
Inter Partes Review Proceedings
1
International Arbitration
1
ITC
1
Jazz Pharmaceuticals
1
Judge Stark
1
Judgment on the Pleadings
1
Justiciable Controversy
1
Lanham Act
1
Lipitor
1
Manufacturing Facilities
1
Marketing
1
Medical Devices
1
Medicare
1
Mensing
1
Method-of-Use
1
Minimum Contacts
1
Misbranding
1
New Guidance
1
Noerr-Pennington Doctrine
1
Non-Disclosure Agreement
1
Off-Label Promotion
1
Off-Label Use
1
Orphan Drugs
1
Par/Paddock
1
Patent-Eligible Subject Matter
1
Patients
1
Pharmacies
1
PLIVA v Mensing
1
Preemption
1
Presumption of Validity
1
Product Hopping
1
Product Labels
1
Proposed Legislation
1
Proposed Regulation
1
Public Meetings
1
Purdue Pharma
1
Real Party in Interest
1
Reissue Patents
1
Remand
1
Research Tools
1
Restrictive Covenants
1
Reversal
1
Reverse Payments
1
Rosuvastatin
1
Royalties
1
Rulemaking Process
1
Sales Contracts
1
Sandoz v Amgen
1
Split of Authority
1
Standard of Proof
1
Standards-Essential Patents
1
Subsidiaries
1
Trade Secrets
1
Warner Chilcott
1
Wyeth